Ian Goodall

2.4k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

Ian Goodall is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Ian Goodall has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Analytical Chemistry. Recurrent topics in Ian Goodall's work include Diabetes Management and Research (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Ian Goodall is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Ian Goodall collaborates with scholars based in United Kingdom, Australia and United States. Ian Goodall's co-authors include W. Garry John, Cas Weykamp, Andrea Mosca, Tadao Hoshino, Kor Miedema, Randie R. Little, Dušan Uhrı́n, Jan‐Olof Jeppsson, William Kew and Helen M. Crews and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Diabetes Care.

In The Last Decade

Ian Goodall

34 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison Study

2004 561 citations Cas Weykamp, Ian Goodall et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Goodall United Kingdom	19	866	397	237	229	228	35	1.8k
Uwe Kobold Germany	20	927 1.1×	621 1.6×	138 0.6×	142 0.6×	125 0.5×	50	2.7k
Terence S. M. Wan China	33	785 0.9×	528 1.3×	313 1.3×	315 1.4×	219 1.0×	129	3.1k
Dietmar Stöckl Belgium	27	492 0.6×	348 0.9×	178 0.8×	141 0.6×	75 0.3×	84	2.0k
Valerie Walker United Kingdom	30	156 0.2×	818 2.1×	222 0.9×	183 0.8×	319 1.4×	112	2.9k
Lothar Siekmann Germany	24	480 0.6×	288 0.7×	161 0.7×	85 0.4×	46 0.2×	83	1.8k
Christian Staub Switzerland	33	328 0.4×	476 1.2×	90 0.4×	308 1.3×	241 1.1×	63	2.5k
Michael Rothe Germany	31	354 0.4×	727 1.8×	60 0.3×	37 0.2×	66 0.3×	122	3.1k
Karen W. Phinney United States	30	263 0.3×	819 2.1×	96 0.4×	234 1.0×	426 1.9×	90	3.0k
Valentina Pirro United States	29	306 0.4×	1.0k 2.6×	82 0.3×	218 1.0×	307 1.3×	65	2.5k
Arthur Karmen United States	25	293 0.3×	1.0k 2.5×	88 0.4×	134 0.6×	315 1.4×	109	3.8k

Countries citing papers authored by Ian Goodall

Since Specialization

Citations

This map shows the geographic impact of Ian Goodall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Goodall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Goodall more than expected).

Fields of papers citing papers by Ian Goodall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Goodall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Goodall. The network helps show where Ian Goodall may publish in the future.

Co-authorship network of co-authors of Ian Goodall

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Goodall. A scholar is included among the top collaborators of Ian Goodall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Goodall. Ian Goodall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broek, Jan van den, Ian Goodall, Despina Tsipi, et al.. (2024). Handheld methanol detector for beverage analysis: interlaboratory validation. Analytical Methods. 16(24). 3859–3866. 3 indexed citations

Kew, William, Ian Goodall, & Dušan Uhrı́n. (2019). Analysis of Scotch Whisky by 1H NMR and chemometrics yields insight into its complex chemistry. Food Chemistry. 298. 125052–125052. 31 indexed citations

Smith, Barry L., et al.. (2019). Rapid Scotch Whisky Analysis and Authentication using Desorption Atmospheric Pressure Chemical Ionisation Mass Spectrometry. Scientific Reports. 9(1). 7994–7994. 21 indexed citations

Ellis, David I., et al.. (2018). Rapid through-container detection of fake spirits and methanol quantification with handheld Raman spectroscopy. The Analyst. 144(1). 324–330. 50 indexed citations

Ward, Stephen, et al.. (2018). Practice and bias in intraoperative pain management: results of a cross-sectional patient study and a survey of anesthesiologists. Journal of Pain Research. Volume 11. 561–570. 10 indexed citations

Stupák, Michal, Ian Goodall, Monika Tomaniová, Jana Pulkrábová, & Jana Hajšlová. (2018). A novel approach to assess the quality and authenticity of Scotch Whisky based on gas chromatography coupled to high resolution mass spectrometry. Analytica Chimica Acta. 1042. 60–70. 61 indexed citations

Ellis, David I., Yun Xu, Howbeer Muhamadali, et al.. (2017). Through-container, extremely low concentration detection of multiple chemical markers of counterfeit alcohol using a handheld SORS device. Scientific Reports. 7(1). 12082–12082. 64 indexed citations

Bantel, Carsten, et al.. (2015). Different measures, different outcomes? Survey into the effectiveness of chronic pain clinics in a London tertiary referral center. Journal of Pain Research. 8. 477–477. 6 indexed citations

Bantel, Carsten, et al.. (2014). The clinical psychologist and the management of inpatient pain: a small case series. Neuropsychiatric Disease and Treatment. 10. 2291–2291. 6 indexed citations

10.

dʼEmden, Michael C, Jonathan E. Shaw, Peter G. Colman, et al.. (2012). The role of HbA1c in the diagnosis of diabetes mellitus in Australia. The Medical Journal of Australia. 197(4). 220–221. 62 indexed citations

11.

Shaw, Jonathan E., Michael C dʼEmden, & Ian Goodall. (2011). Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes?. The Medical Journal of Australia. 195(1). 7–8. 10 indexed citations

12.

Goodall, Ian, et al.. (2007). Desirable performance standards for HbA(1c) analysis precision, accuracy and standardisation. Clinical Chemistry and Laboratory Medicine (CCLM). 45(8). 5 indexed citations

13.

Goodall, Ian, et al.. (2007). Desirable performance standards for HbA1c analysis – precision, accuracy and standardisation Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA). Clinical Chemistry and Laboratory Medicine (CCLM). 45(8). 1083–97. 49 indexed citations

14.

John, W. Garry, Andrea Mosca, Cas Weykamp, & Ian Goodall. (2007). HbA1c standardisation: history, science and politics.. PubMed. 28(4). 163–8. 40 indexed citations

15.

John, Andrew St, et al.. (2005). Nurse-based evaluation of point-of-care assays for glycated haemoglobin. Clinica Chimica Acta. 365(1-2). 257–263. 36 indexed citations

16.

Tsalamandris, Con, et al.. (1998). Long-Term Intraindividual Variability of Serum Lipids in Patients With Type I and Type II Diabetes. Journal of Diabetes and its Complications. 12(4). 208–214. 8 indexed citations

17.

Gilbert, Richard E., et al.. (1996). Interlaboratory Variation of GHb Assays in Victoria, Australia. Diabetes Care. 19(7). 730–734. 13 indexed citations

18.

Gilbert, Richard E., Con Tsalamandris, Leon A. Bach, et al.. (1993). Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney International. 44(4). 855–859. 79 indexed citations

19.

Cooper, Mark E., Dimitria Vranes, Sianna Panagiotopoulos, et al.. (1990). HYPERLIPIDAEMIA INCREASES ALBUMINURIA IN HYPERTENSIVE AND NORMOTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 17(3). 225–228. 3 indexed citations

20.

Goodall, Ian, et al.. (1989). First Report of HB Long Island-Marseille in Australia - A Chance Discovery. Hemoglobin. 13(5). 515–520.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact